Atlas Trials

ViGenCell Inc.

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch ViGenCell Inc.

RecordFirmDate
A Prospective, Open Label, Dose-escalation, SAD/MAD, Multicenter, 24weeks, Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and Pharmacodynamics of Investigational Product (VM-001) in Patients With Graft-versus-host Disease(GvHD) (NCT05276076)ViGenCell Inc.2022-11-20
VT-EBV-N for Treatment of Severe in EBV Positive Extranodal NK/T Cell Lymphoma Patients (NCT03671850)ViGenCell Inc.2019-04-09

Track ViGenCell Inc. automatically

Every clearance here is in the API, with alerts when new ones post.